Fairchem Organics Limited (FAIRCHEMOR) - Net Assets
Based on the latest financial reports, Fairchem Organics Limited (FAIRCHEMOR) has net assets worth Rs2.63 Billion INR (≈ $28.45 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs3.91 Billion ≈ $42.28 Million USD) and total liabilities (Rs1.28 Billion ≈ $13.84 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Fairchem Organics Limited (FAIRCHEMOR) total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs2.63 Billion |
| % of Total Assets | 67.28% |
| Annual Growth Rate | 12.68% |
| 5-Year Change | 13.31% |
| 10-Year Change | N/A |
| Growth Volatility | 16.75 |
Fairchem Organics Limited - Net Assets Trend (2020–2026)
This chart illustrates how Fairchem Organics Limited's net assets have evolved over time, based on quarterly financial data. Check FAIRCHEMOR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Fairchem Organics Limited (2020–2026)
The table below shows the annual net assets of Fairchem Organics Limited from 2020 to 2026. For live valuation and market cap data, see Fairchem Organics Limited market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs2.63 Billion ≈ $28.45 Million |
-12.91% |
| 2025-03-31 | Rs3.02 Billion ≈ $32.66 Million |
+4.17% |
| 2024-03-31 | Rs2.90 Billion ≈ $31.36 Million |
+11.83% |
| 2023-03-31 | Rs2.59 Billion ≈ $28.04 Million |
+11.68% |
| 2022-03-31 | Rs2.32 Billion ≈ $25.11 Million |
+37.58% |
| 2021-03-31 | Rs1.69 Billion ≈ $18.25 Million |
+31.24% |
| 2020-03-31 | Rs1.29 Billion ≈ $13.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Fairchem Organics Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs125.96 Million | 4.79% |
| Other Components | Rs2.50 Billion | 95.21% |
| Total Equity | Rs2.63 Billion | 100.00% |
Fairchem Organics Limited Competitors by Market Cap
The table below lists competitors of Fairchem Organics Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bright Sheland International Co Ltd
TWO:4556
|
$110.75 Million |
|
BICO Group AB
ST:BICO
|
$110.76 Million |
|
Soquicom
SN:SOQUICOM
|
$110.77 Million |
|
Super Energy Corporation Public Company Limited
BK:SUPER
|
$110.82 Million |
|
Riverview Bancorp Inc
NASDAQ:RVSB
|
$110.74 Million |
|
GAMSUNG Corporation Co. Ltd
KQ:036620
|
$110.71 Million |
|
Captor Therapeutics S.A.
WAR:CTX
|
$110.67 Million |
|
Mitrajaya Holdings Bhd
KLSE:9571
|
$110.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fairchem Organics Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 3,020,306,000 to 2,630,403,000, a change of -389,903,000 (-12.9%).
- Net income of 55,405,000 contributed positively to equity growth.
- Dividend payments of 97,657,000 reduced retained earnings.
- Share repurchases of 351,382,000 reduced equity.
- Other comprehensive income decreased equity by 895,805,000.
- Other factors increased equity by 899,536,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs55.41 Million | +2.11% |
| Dividends Paid | Rs97.66 Million | -3.71% |
| Share Repurchases | Rs351.38 Million | -13.36% |
| Other Comprehensive Income | Rs-895.80 Million | -34.06% |
| Other Changes | Rs899.54 Million | +34.2% |
| Total Change | Rs- | -12.91% |
Book Value vs Market Value Analysis
This analysis compares Fairchem Organics Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 8.23x to 4.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-03-31 | Rs98.74 | Rs813.00 | x |
| 2021-03-31 | Rs129.59 | Rs813.00 | x |
| 2022-03-31 | Rs178.29 | Rs813.00 | x |
| 2023-03-31 | Rs199.11 | Rs813.00 | x |
| 2024-03-31 | Rs222.67 | Rs813.00 | x |
| 2025-03-31 | Rs231.82 | Rs813.00 | x |
| 2026-03-31 | Rs203.20 | Rs813.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fairchem Organics Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.11%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.21%
- • Asset Turnover: 1.18x
- • Equity Multiplier: 1.49x
- Recent ROE (2.11%) is below the historical average (17.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 26.99% | 11.35% | 1.39x | 1.72x | Rs218.48 Million |
| 2021 | 25.18% | 10.73% | 1.53x | 1.53x | Rs256.11 Million |
| 2022 | 29.25% | 10.57% | 1.98x | 1.40x | Rs446.91 Million |
| 2023 | 16.78% | 6.72% | 1.89x | 1.32x | Rs175.75 Million |
| 2024 | 13.97% | 6.52% | 1.86x | 1.15x | Rs115.07 Million |
| 2025 | 7.28% | 4.09% | 1.34x | 1.33x | Rs-82.29 Million |
| 2026 | 2.11% | 1.21% | 1.18x | 1.49x | Rs-207.64 Million |
Industry Comparison
This section compares Fairchem Organics Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $12,539,578,100
- Average return on equity (ROE) among peers: 8.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fairchem Organics Limited (FAIRCHEMOR) | Rs2.63 Billion | 26.99% | 0.49x | $110.75 Million |
| Aarti Industries Limited (AARTIIND) | $56.05 Billion | 5.90% | 0.98x | $1.91 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $44.03 Million |
| ABM International Limited (ABMINTLLTD) | $127.92 Million | -37.56% | 1.23x | $4.33 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $10.31 Billion | 14.16% | 0.12x | $392.05 Million |
| Aether Industries Limited (AETHER) | $20.63 Billion | 4.00% | 0.16x | $2.17 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $2.69 Billion | 18.78% | 1.53x | $1.60 Billion |
| Alkali Metals Limited (ALKALI) | $513.46 Million | 2.20% | 1.13x | $7.55 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $1.50 Billion | 30.09% | 1.66x | $1.01 Billion |
| Ami Organics Limited (AMIORG) | $576.82 Million | 32.06% | 1.70x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $30.82 Billion | 3.03% | 0.71x | $1.49 Billion |
About Fairchem Organics Limited
Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals. It provides nutraceuticals comprising natural and mixed tocopherol and sterol concentrates; and oleo chemicals, such as dimer, isostearic, monobasic, linoleic/soya fatty, stearic, palmitic, and distilled fatty acid products, as well as monobasic acid. The company operates in India, East Asia… Read more